Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test

21st January 2019 Uncategorised 0

AbbVie and Johnson & Johnson’s blockbuster Imbruvica is approved to treat six diseases, but it looks like pancreatic cancer won’t be its seventh.

More: Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Source: fierce